Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy.
Brose MS, Capdevila J, Elisei R, Bastholt L, Führer-Sakel D, Leboulleux S, Sugitani I, Taylor MH, Wang Z, Wirth LJ, Worden FP, Bernard J, Caferra P, Colzani RM, Liu S, Schlumberger M.
Brose MS, et al. Among authors: bernard j.
Endocr Relat Cancer. 2024 Jul 2;31(8):e230354. doi: 10.1530/ERC-23-0354. Print 2024 Aug 1.
Endocr Relat Cancer. 2024.
PMID: 38828895
Free PMC article.
Clinical Trial.